kaempferol-7-methyl ether

Also Known As:

rhamnocitrin

Networked: 11 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavonols: 321
        Kaempferols: 1
        kaempferol-7-methyl ether: 11
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavonols: 321
        Kaempferols: 1
        kaempferol-7-methyl ether: 11

Experts

1.	Chen, Zong-Tsi: 2 articles (05/2009 - 11/2007)
2.	Wu, Ming-Jiuan: 2 articles (05/2009 - 11/2007)
3.	Yen, Jui-Hung: 2 articles (05/2009 - 11/2007)
4.	Patel, Dinesh Kumar: 1 article (06/2022)
5.	Cai, Xianbin: 1 article (05/2022)
6.	Xu, Xuefen: 1 article (05/2022)
7.	Dong, Zhewen: 1 article (01/2022)
8.	He, Wen: 1 article (01/2022)
9.	Lan, Huan: 1 article (01/2022)
10.	Li, Wanying: 1 article (01/2022)

Related Diseases

1.	Pheochromocytoma 08/01/2014 - "These results correlate with literature data about protective effects of kempferol and rhamnocitrin on oxidative damage in rat pheochromocytoma PC12 cells. " 05/15/2009 - "Our aim of research is to investigate the protective effects and mechanisms of kaempferol and rhamnocitrin (kaempferol-7-methyl ether) on oxidative damage in rat pheochromocytoma PC12 cells induced by a limited supply of serum and hydrogen peroxide (H2O2). "
2.	Atherosclerosis 11/28/2007 - "The aim of this study is to investigate the function of kaempferol and rhamnocitrin on prevention of atherosclerosis. " 11/28/2007 - "Current evidences indicate that kaempferol and rhamnocitrin not only protect LDL from oxidation but also prevent atherogenesis through suppressing macrophage uptake of oxLDL."
3.	Fibrosis (Cirrhosis) 07/01/2022 - "Rhamnocitrin decreases fibrosis of ovarian granulosa cells by regulating the activation of the PPARγ/NF-κB/TGF-β1/Smad2/3 signaling pathway mediated by Wisp2." 01/01/2022 - "Rhamnocitrin Attenuates Ovarian Fibrosis in Rats with Letrozole-Induced Experimental Polycystic Ovary Syndrome."
4.	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/01/2021 - "These targets potentially participate in processes regulated by transmembrane receptor protein tyrosine kinase, ERBB2, and et al. Molecular docking results predicted high affinity interactions between three components (rhamnazin, rhamnetin, and rhamnocitrin) and the potential targets, suggesting that TGF-β is the most important potential target of NFE in the treatment of pulmonary fibrosis. "
5.	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/01/2022 - "Rhamnocitrin Attenuates Ovarian Fibrosis in Rats with Letrozole-Induced Experimental Polycystic Ovary Syndrome."

Related Drugs and Biologics

1.	kaempferol
2.	Hydrogen Peroxide (Hydroperoxide)
3.	rhamnetin
4.	Phytochemicals
5.	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
6.	Ether (Diethyl Ether)
7.	Diethylnitrosamine (N-Nitrosodiethylamine)
8.	Dibutyl Phthalate (Butyl Phthalate)
9.	Antioxidants
10.	Letrozole (Femara)